Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Lidocaine recalled?

Yes — there is an active recall. 61 ongoing FDA recalls mention Lidocaine (366 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Lidocaine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Lidocaine recalls on record

none so far in 2026; 366 on record, newest first
Class II · Moderate risk

LidoPro (lidocaine 4%, menthol 5%, methyl salicylate 4%)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Ongoing Stability / shelf life Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 53225-1023-1 D-1278-2020
Class II · Moderate risk

LidoPatch (lidocaine HCl 3.6%, menthol 1.25%)

CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.

Ongoing Stability / shelf life Wuhan Bingbing Pharmaceutical Co., Ltd. NDC 10882-527-01 D-1277-2020
Class II · Moderate risk

Lidocaine HCL

Lack of Assurance of Sterility

Terminated Sterility / contamination Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical NDC 71283-1011-5 D-0962-2020
Class II · Moderate risk

Lidocaine Hydroclhoride Jelly USP

cGMP Deviations: firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.

Terminated Particulate / foreign matter Akorn, Inc. NDC 17478-711-30 D-1878-2019
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-077-14 D-1861-2019
Class II · Moderate risk

Soothing Sore Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-074-05 D-1860-2019
Class II · Moderate risk

Superior Pain & Itch Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-073-14 D-1859-2019
Class II · Moderate risk

Superior Pain & Itch Relief

Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.

Terminated Wrong potency / content Ridge Properties, LLC NDC 69804-070-05 D-1858-2019
Class II · Moderate risk

PRE-TAT (lidocaine)

Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay.

Terminated Microbial contamination Ridge Properties, LLC NDC 69804-019-14 D-1857-2019